Perisynaptic matrix gene variants underlie DystoniaGeneNet endophenotypes in isolated focal dystonia
- 1Massachusetts General Hospital
Abstract
Isolated focal dystonia is a rare movement disorder characterized by abnormalities in brain structure and function. The genes underlying isolated focal dystonia are not fully elucidated, and genetic studies are constrained by incomplete penetrance and small family sizes. Neuroimaging endophenotypes shared by patients and unaffected relatives can reveal genetic liability independently of clinical manifestation and offer a strategy for advancing gene discovery. We developed DystoniaGeneNet, a 3D convolutional neural network that predicts familial status from T1-weighted brain MRIs. We then used its predictions to guide genetic analyses in isolated focal dystonia. DystoniaGeneNet was trained on 40 patients with familial laryngeal dystonia and 40 healthy controls, then applied to independent cohorts of 21 patients with familial isolated focal dystonia, 364 patients with sporadic dystonia, and 98 unaffected relatives. Model predictions were incorporated into variant prioritization and segregation analysis in 214 individuals with whole-exome sequencing data, and results were replicated in another 738 independent exomes, in genetic data from a hospital-based biobank (892 dystonia cases, 2,475 controls), and in the All of Us Research Program genetic data (1,343 dystonia cases, 6,840 controls). DystoniaGeneNet discriminated familial dystonia from healthy controls in the training set and correctly classified 85.7% of independent familial cases, using a biomarker centred on the corpus callosum and inferior temporal gyrus. Across the discovery and replication cohorts, we identified rare, likely pathogenic genetic variants in RAP1GAP and TNN segregating with disease in families. Additional variants were found in singletons with isolated focal dystonia. In patients with clinically sporadic dystonia but predicted to have familial features, we observed multiple rare variants in ITSN2, including three high-confidence loss-of-function variants, and an enrichment of damaging missense variants in its Dbl homology domain. To determine the functional impact of discovered genetic variants, we assessed gene expression and splicing via qPCR and RNA sequencing (n = 74), revealing reduced RAP1GAP and ITSN2 expression in variant carriers. At the pathway level, rare nonsynonymous variants in brain-expressed matrisome genes were associated with dystonia (P = 0.012). Our strategy utilizing a deep learning-derived neuroimaging endophenotype to empower gene discovery uncovered RAP1GAP, TNN, and ITSN2 as novel genes associated with isolated focal dystonia. These genes converge on perisynaptic extracellular matrix-synapse signalling, implicating a mechanism linked to synaptic plasticity deficits, and identifying a molecular substrate for network-level brain abnormalities that characterize this disorder. Further, we exemplify a generalizable framework for leveraging endophenotypes in rare neurogenetic diseases with incomplete penetrance.
Related
- Recurring and isolated intronic FGFR1 variants as an underdiagnosed cause of congenital hypogonadotropic hypogonadism
- Integrating corneal endophenotypes with classic GWAS approaches identifies novel keratoconus loci
- How Many Factors Underlie the WAIS-5? Evidence From the Australian and New Zealand Standardization Sample.
- Altered Individualized Structural Covariance Networks Underlie Depressive and Anxiety Symptoms in Chronic Insomnia Disorder: A Dynamic Time Warping Graph Theory Study
- Discrete cortico-hippocampal circuit states underlie mood state transitions in depression
BibTeX
@misc{domingo2026perisynaptic,
title = {{Perisynaptic matrix gene variants underlie DystoniaGeneNet endophenotypes in isolated focal dystonia}},
author = {A. Domingo and D. Yao and N. Kshatriya and K. Mangkalaphiban and G. Battistella and L. O'Flynn and B. Reese and M. Hincher and R. Yadav and N. Sharma and L. Williams and C. Fearon and O. Killian and R. B. Reilly and M. Hutchinson and D. Raymond and R. Saunders-Pullman and S. Bressman and S. Frucht and M. Talkowski and K. Simonyan and L. Ozelius},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.19.26365640},
url = {https://www.medrxiv.org/content/10.64898/2026.10.19.26365640v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Perisynaptic matrix gene variants underlie DystoniaGeneNet endophenotypes in isolated focal dystonia
AU - A. Domingo
AU - D. Yao
AU - N. Kshatriya
AU - K. Mangkalaphiban
AU - G. Battistella
AU - L. O'Flynn
AU - B. Reese
AU - M. Hincher
AU - R. Yadav
AU - N. Sharma
AU - L. Williams
AU - C. Fearon
AU - O. Killian
AU - R. B. Reilly
AU - M. Hutchinson
AU - D. Raymond
AU - R. Saunders-Pullman
AU - S. Bressman
AU - S. Frucht
AU - M. Talkowski
AU - K. Simonyan
AU - L. Ozelius
PY - 2026
DA - 2026/10/19
PB - medRxiv
DO - 10.64898/2026.10.19.26365640
UR - https://www.medrxiv.org/content/10.64898/2026.10.19.26365640v1
AB - Isolated focal dystonia is a rare movement disorder characterized by abnormalities in brain structure and function. The genes underlying isolated focal dystonia are not fully elucidated, and genetic studies are constrained by incomplete penetrance and small family sizes. Neuroimaging endophenotypes shared by patients and unaffected relatives can reveal genetic liability independently of clinical manifestation and offer a strategy for advancing gene discovery. We developed DystoniaGeneNet, a 3D convolutional neural network that predicts familial status from T1-weighted brain MRIs. We then used its predictions to guide genetic analyses in isolated focal dystonia. DystoniaGeneNet was trained on 40 patients with familial laryngeal dystonia and 40 healthy controls, then applied to independent cohorts of 21 patients with familial isolated focal dystonia, 364 patients with sporadic dystonia, and 98 unaffected relatives. Model predictions were incorporated into variant prioritization and segregation analysis in 214 individuals with whole-exome sequencing data, and results were replicated in another 738 independent exomes, in genetic data from a hospital-based biobank (892 dystonia cases, 2,475 controls), and in the All of Us Research Program genetic data (1,343 dystonia cases, 6,840 controls). DystoniaGeneNet discriminated familial dystonia from healthy controls in the training set and correctly classified 85.7% of independent familial cases, using a biomarker centred on the corpus callosum and inferior temporal gyrus. Across the discovery and replication cohorts, we identified rare, likely pathogenic genetic variants in RAP1GAP and TNN segregating with disease in families. Additional variants were found in singletons with isolated focal dystonia. In patients with clinically sporadic dystonia but predicted to have familial features, we observed multiple rare variants in ITSN2, including three high-confidence loss-of-function variants, and an enrichment of damaging missense variants in its Dbl homology domain. To determine the functional impact of discovered genetic variants, we assessed gene expression and splicing via qPCR and RNA sequencing (n = 74), revealing reduced RAP1GAP and ITSN2 expression in variant carriers. At the pathway level, rare nonsynonymous variants in brain-expressed matrisome genes were associated with dystonia (P = 0.012). Our strategy utilizing a deep learning-derived neuroimaging endophenotype to empower gene discovery uncovered RAP1GAP, TNN, and ITSN2 as novel genes associated with isolated focal dystonia. These genes converge on perisynaptic extracellular matrix-synapse signalling, implicating a mechanism linked to synaptic plasticity deficits, and identifying a molecular substrate for network-level brain abnormalities that characterize this disorder. Further, we exemplify a generalizable framework for leveraging endophenotypes in rare neurogenetic diseases with incomplete penetrance.
ER -